Evidence map›Paper›PMID 36139599›Full record

ArticleCancers2022

Novel Human Artificial Intelligence Hybrid Framework Pinpoints Thyroid Nodule Malignancy and Identifies Overlooked Second-Order Ultrasonographic Features.

Xiaohong Jia, Zehao Ma, Dexing Kong, Yamin Li, Hairong Hu, Ling Guan, Jiping Yan, Ruifang Zhang, Ying Gu, Xia Chen and 11 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 12 institutions in 1 country.

Xiaohong JiaDepartment of Ultrasound, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.
Zehao MaSchool of Mathematical Sciences, Zhejiang University, Hangzhou 310013, China.
Dexing KongSchool of Mathematical Sciences, Zhejiang University, Hangzhou 310013, China.
Yamin LiDepartment of Ultrasound, Puyang People's Hospital, Puyang 457005, China.
Hairong HuDemetics Medical Technology, Hangzhou 310012, China.
Ling GuanDepartment of Ultrasound, Gansu Provincial Cancer Hospital, Lanzhou 730050, China.
Jiping YanDepartment of Ultrasound, Shanxi Provincial People's Hospital, Taiyuan 030012, China.
Ruifang ZhangDepartment of Ultrasound, The First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, China.
Ying GuDepartment of Ultrasound, Affiliated Hospital of Guizhou Medical University, Guiyang 550001, China.
Xia ChenDepartment of Ultrasound, Affiliated Hospital of Guizhou Medical University, Guiyang 550001, China.
Liying ShiDepartment of Ultrasound, Affiliated Hospital of Guizhou Medical University, Guiyang 550001, China.
Xiaomao LuoDepartment of Ultrasound, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Kunming 650031, China.
Qiaoying LiDepartment of Ultrasound Diagnostics, Tangdu Hospital, Fourth Military Medical University, Xi'an 710038, China.
Baoyan BaiDepartment of Ultrasound, Affiliated Hospital of Yan'an University, School of Medicine, Yan'an University, Yan'an 716000, China.
Xinhua YeDepartment of Ultrasound, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Hong ZhaiDepartment of Ultrasound, Traditional Chinese Medical Hospital of Xinjiang, Urumqi 830000, China.
Hua ZhangDepartment of Ultrasound, Anyang Tumor Hospital, The Fourth Affiliated Hospital of Henan University of Science and Technology, Anyang 455000, China.
Yijie DongDepartment of Ultrasound, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.
Lei XuZhejiang Qiushi Institute for Mathematical Medicine, Hangzhou 311121, China.ORCID 0000-0002-1165-6246
Jianqiao ZhouDepartment of Ultrasound, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.
Caau
Guiyang Medical University · CNRuijin Hospital · CNAir Force Medical University · CNAnyang Tumor Hospital · CNFirst Affiliated Hospital of Zhengzhou University · CNGansu Provincial Hospital · CNJiangsu Province Hospital · CNKunming Medical University · CNShanxi Medical University · CNYan'an University · CNZhejiang Normal University · CNZhejiang University · CN

Funding

National Natural Science Foundation of China 12090020, 12090025 and 82071928
6 · The paper itself

Abstract

We present a Human Artificial Intelligence Hybrid (HAIbrid) integrating framework that reweights Thyroid Imaging Reporting and Data System (TIRADS) features and the malignancy score predicted by a convolutional neural network (CNN) for nodule malignancy stratification and diagnosis. We defined extra ultrasonographical features from color Doppler images to explore malignancy-relevant features. We proposed Gated Attentional Factorization Machine (GAFM) to identify second-order interacting features trained via a 10 fold distribution-balanced stratified cross-validation scheme on ultrasound images of 3002 nodules all finally characterized by postoperative pathology (1270 malignant ones), retrospectively collected from 131 hospitals. Our GAFM-HAIbrid model demonstrated significant improvements in Area Under the Curve (AUC) value (p-value < 10−5), reaching about 0.92 over the standalone CNN (~0.87) and senior radiologists (~0.86), and identified a second-order vascularity localization and morphological pattern which was overlooked if only first-order features were considered. We validated the advantages of the integration framework on an already-trained commercial CNN system and our findings using an extra set of ultrasound images of 500 nodules. Our HAIbrid framework allows natural integration to clinical workflow for thyroid nodule malignancy risk stratification and diagnosis, and the proposed GAFM-HAIbrid model may help identify novel diagnosis-relevant second-order features beyond ultrasonography.

Indexed as

feature selectioninterpretable deep learningmalignancy risk stratificationradiologysecond-order feature interactionthyroid nodule

Identifiers

PMID36139599
PMCPMC9497166
OpenAlexW4295745270

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.